Alnylam Pharma (ALNY) Q3 2025 Earnings Report
MX:ALNY Q3 2025 EPS Results
- Actual EPS
- MXN 34.58
- Consensus EPS
- MXN 10.54
- Beat/Miss
- Beat by +MXN 24.04
- One Year Ago EPS
- -MXN 16.35
MX:ALNY Q3 2025 Revenue Results
- Actual Revenue
- MXN 23.47B
- Expected Revenue
- MXN 18.03B
- Beat/Miss
- Beat by +MXN 5.44B
- YoY Revenue Growth
- +149.35%
Earnings Announcement Details
- Quarter
- Q3 2025
- Date
- 10/30/2025
- Time
- Before Open
- Conference Call
- Thursday, October 30, 2025
MX:ALNY Upcoming Earnings
Alnylam Pharma's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q3 2025 Earnings Call Audio
MX:ALNY Q3 2025 Earnings Call
0:00 / 0:00
Q3 2025 Earnings Slide Deck
Q3 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ALNY Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 32.30- | 15.41 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 31.19295.41 | 34.58 | 754.35% (+260.83) | |
| Jul 30, 2026 | 2026 (Q2) | 30.6322.74 | -9.58 | 337.25% (+32.32) | |
| Apr 30, 2026 | 2026 (Q1) | 16.3928.38 | -8.27 | 443.18% (+36.64) | |
| Feb 12, 2026 | 2025 (Q4) | 21.6115.41 | -12.21 | 226.15% (+27.62) | |
| Oct 30, 2025 | 2025 (Q3) | 10.5434.58 | -16.35 | 311.49% (+50.93) | |
| Jul 31, 2025 | 2025 (Q2) | -10.22-9.58 | -2.44 | -292.31% (-7.14) | |
| May 01, 2025 | 2025 (Q1) | -16.72-8.27 | -9.77 | 15.38% (+1.50) | |
| Feb 13, 2025 | 2024 (Q4) | -11.12-12.21 | -20.67 | 40.91% (+8.46) | |
| Oct 31, 2024 | 2024 (Q3) | -17.23-16.35 | 21.61 | -175.65% (-37.96) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
